You can buy or sell DFFN and other stocks, options, ETFs, and crypto commission-free!
Diffusion Pharmaceuticals Inc. Common Stock, also called Diffusion Pharmaceuticals, is a clinical stage company, which engages in the development of treatment for life threatening conditions. Read More It offers Trans Sodium Crocetinate. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. The listed name for DFFN is Diffusion Pharmaceuticals Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 11, After Hours